logo-loader
viewArgentex

Argentex taps into rising foreign exchange demand

Snapshot

The corporate forex firm doubled its operating profit and booked a third more clients in the last six months, saying political uncertainty in UK increases demand for currency exchange

Argentex -

Quick facts: Argentex

Price: 112.5 GBX

AIM:AGFX
Market: AIM
Market Cap: £127.36 m
Follow

What it does

Argentex Group PLC (LON:AGFX) specialises in providing corporate foreign exchange for institutions, corporates and high net worth private individuals.

How it’s doing

The foreign exchange services provider, which made its AIM debut with a £12mln June fundraising, said in November its outlook was “strong”.

“We have barely a fraction of a market worth hundreds of billions of pounds,” said Carl Jani, co-chief executive.

"’How can we get more?’ is the question we ask ourselves every morning.”

 

What the boss says

Co-chief executive Harry Adams said that opportunities for the firm are opening up: “We’re seeing that 85% of corporates still trade using their bank for foreign exchange, so the market is absolutely huge.”

 

Blue Sky 

Broker Numis says Argentex's foreign exchange service to small and medium-sized enterprises is a “very high margin business", with an operating margin of 46%.

Unlike most of the rest of the sector, Argentex has almost no market or macro risk.

Numis also pointed out that Argentex is very well diversified by customer and geography, and has "little regulatory risk compared to the rest of the sector”.

"We also see potential for international trades to grow", the broker added, as Argentex currently generates 72% of its revenue from UK clients.
 

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Argentex named herein, including the promotion by the Company of Argentex in any Content on the Site, the Company receives from said issuer...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Investor Update: SkinBio signs commercial deal with chemical giant Croda

Headlines from the Proactive UK newsroom. SkinBioTherapeutics (LON:SBTX) has signed a commercial and manufacturing agreement for its Skinbiotix technology with speciality chemical giant Croda.  It is the first major deal for the product with Croda to design and manufacture a new active...

on 20/11/19

2 min read